- Home
- PTCT vs TRNO Comparison
PTCT vs TRNO Comparison
Compare PTCT & TRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- TRNO
- Stock Information
- Founded
- PTCT 1998
- TRNO 2009
- Country
- PTCT United States
- TRNO United States
- Employees
- PTCT N/A
- TRNO N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- TRNO Real Estate
- Sector
- PTCT Health Care
- TRNO Finance
- Exchange
- PTCT Nasdaq
- TRNO Nasdaq
- Market Cap
- PTCT 5.3B
- TRNO 6.0B
- IPO Year
- PTCT 2013
- TRNO 2010
- Fundamental
- Price
- PTCT $68.31
- TRNO $57.13
- Analyst Decision
- PTCT Buy
- TRNO Buy
- Analyst Count
- PTCT 15
- TRNO 10
- Target Price
- PTCT $67.67
- TRNO $64.40
- AVG Volume (30 Days)
- PTCT 949.1K
- TRNO 591.5K
- Earning Date
- PTCT 11-04-2025
- TRNO 11-03-2025
- Dividend Yield
- PTCT N/A
- TRNO 3.64%
- EPS Growth
- PTCT N/A
- TRNO 40.84
- EPS
- PTCT 7.72
- TRNO 2.52
- Revenue
- PTCT $1,764,929,000.00
- TRNO $425,998,000.00
- Revenue This Year
- PTCT $119.02
- TRNO $21.54
- Revenue Next Year
- PTCT N/A
- TRNO $10.87
- P/E Ratio
- PTCT $8.85
- TRNO $22.64
- Revenue Growth
- PTCT 96.00
- TRNO 22.17
- 52 Week Low
- PTCT $35.95
- TRNO $48.18
- 52 Week High
- PTCT $69.88
- TRNO $69.20
- Technical
- Relative Strength Index (RSI)
- PTCT 64.81
- TRNO 40.25
- Support Level
- PTCT $66.00
- TRNO $60.74
- Resistance Level
- PTCT $69.88
- TRNO $61.55
- Average True Range (ATR)
- PTCT 2.24
- TRNO 1.32
- MACD
- PTCT -0.30
- TRNO -0.36
- Stochastic Oscillator
- PTCT 71.61
- TRNO 11.19
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About TRNO Terreno Realty Corporation
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.